Periodic Reporting for period 1 - RE-IMMUNE (Intelligent Nano-encapsuled siRNA for Restoring Immune Cell Response to Cancer)

WHY: To effectively bring siRNA-based therapeutic for cancer immunotherapy into the hands of clinicians requires the development of fundamentally new mechanisms to overcome current drawbacks. Accomplishing this will enable more efficient treatment with less side effects.WHAT:...